Reinforces the view that the HIV strategy is the important one for this company that will lead it to success, as it was and as it shall be.
The covid research might be worthwhile and beneficial but is a long shot at this stage.
Hopefully this will help stir things along for phase 3 funding from a big pharma.
Reinforces the view that the HIV strategy is the important one...
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.2¢ |
Change
-0.003(5.45%) |
Mkt cap ! $46.91M | |||
| Open | High | Low | Value | Volume |
| 5.4¢ | 5.6¢ | 5.2¢ | $63.28K | 1.198M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 23859 | 5.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.5¢ | 33995 | 1 |
View Market Depth
| Last trade - 15.51pm 10/06/2024 (20 minute delay) ? |
|
|||||
|
Last
5.2¢ |
Change
-0.003 ( 5.45 %) |
||||
| Open | High | Low | Volume | ||
| 5.4¢ | 5.5¢ | 5.2¢ | 64903 | ||
| Last updated 15.35pm 10/06/2024 ? | |||||
| BIT (ASX) Chart |